CytoReason vs Preventive AI
CytoReason vs Preventive AI, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CytoReason is on 68/100 and Preventive AI on 45/100.
Where each one leads
CytoReason
- our overall score: 68/100 against 45/100
- headcount: 116 against 7
- LinkedIn following: 12,830 against 6
Preventive AI
Leads on none of the measures we hold for both companies.
At a glance
| Measure | CytoReason | Preventive AI |
|---|---|---|
| What it is | Develops a computational model of the human body for drug discovery and development. | AI-powered personalized screening for early disease detection using non-invasive methods. |
| Category | Healthcare, Drug Discovery, Clinical Development, Biomarkers | Healthcare, HealthTech, MedTech, AI-Driven Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Platform |
| Founded | 2016 | 2022 |
| Headquarters | Tel Aviv, Israel | New York, United States |
| Status | Active | Inactive |
Size, funding and growth
| Measure | CytoReason | Preventive AI |
|---|---|---|
| Employees | 116 | 7 |
| Headcount growthLast 12 months | +13.7% | Not published |
| Total funding | $128M | Not published |
| Latest round | Series B | Not published |
| LinkedIn followers | 12,830 | 6 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CytoReason | Preventive AI |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 68/100 | 45/100 |
| Traction | 60/100 | 9/100 |
| Team | 70/100 | 70/100 |
| Community | Not published | 15/100 |
| Search visibility | 30/100 | 17/100 |
| Quality | 78/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (22/100) |
| Domain ratingLink authority, 0-100 | 40/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CytoReason | Preventive AI |
|---|---|---|
| Analytics | Segment | Not detected |
CytoReason vs Preventive AI: common questions
Which is better, CytoReason or Preventive AI?
On our 0-100 score CytoReason rates higher (68/100 against 45/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do CytoReason and Preventive AI compare on the numbers?
CytoReason leads on our overall score (68/100 against 45/100), headcount (116 against 7), LinkedIn following (12,830 against 6).
Read the full CytoReason review and pricing or the Preventive AI review and pricing. You can also browse other CytoReason alternatives we track.